| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $3.1B | $2.5B | $2.1B | $1.7B | $1.4B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| R&D Expense | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — |
| Operating Income | $0.5B | $0.4B | $0.4B | $0.3B | $0.2B |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $-0.0B |
| EPS (Basic) | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $10.6B | $9.6B | $7.2B | $6.4B | $5.5B |
| Current Assets | $5.1B | $4.8B | $4.3B | $3.9B | $3.0B |
| Cash & Equivalents | $0.2B | $0.5B | $1.8B | $1.8B | $1.1B |
| Total Liabilities | $9.3B | $8.6B | $6.3B | $5.6B | $4.9B |
| Current Liabilities | $5.2B | $4.5B | $3.7B | $3.1B | $2.9B |
| Stockholders' Equity | $0.6B | $0.6B | $0.6B | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.5B | $0.5B | $0.3B | $0.3B |
| Investing Cash Flow | $-0.8B | $-1.8B | $-0.5B | $-0.0B | $-0.5B |
| Capital Expenditures | — | — | — | — | — |
| Financing Cash Flow | $0.1B | $1.2B | $-0.0B | $0.3B | $0.4B |